Your browser doesn't support javascript.
loading
The KINETIC phase 2 randomized controlled trial of oral pamapimod-pioglitazone in non-critically ill COVID-19 inpatients.
Fumeaux, Thierry; Berger, Claudia; Bausch, Alexander; Wright, Matthew; Vilimanovich, Urosh; Soldatovic, Ivan; Vehreschild, Maria J G T.
Afiliación
  • Fumeaux T; Kinarus Therapeutics AG, Technologiepark Basel, Hochbergerstrasse 60C, 4057 Basel, Switzerland.
  • Berger C; Kinarus Therapeutics AG, Technologiepark Basel, Hochbergerstrasse 60C, 4057 Basel, Switzerland.
  • Bausch A; Kinarus Therapeutics AG, Technologiepark Basel, Hochbergerstrasse 60C, 4057 Basel, Switzerland.
  • Wright M; Kinarus Therapeutics AG, Technologiepark Basel, Hochbergerstrasse 60C, 4057 Basel, Switzerland.
  • Vilimanovich U; Wemedoo AG, Sumpfstrasse 24, 6312 Steinhausen, Switzerland.
  • Soldatovic I; Wemedoo AG, Sumpfstrasse 24, 6312 Steinhausen, Switzerland.
  • Vehreschild MJGT; Department of Internal Medicine II, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, 60596 Frankfurt Am Main, Germany.
iScience ; 26(10): 108038, 2023 Oct 20.
Article en En | MEDLINE | ID: mdl-37876609
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: IScience Año: 2023 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: IScience Año: 2023 Tipo del documento: Article País de afiliación: Suiza